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14-3-3 Regulates Actin Dynamics by Stabilizing
Phosphorylated Cofilin
phorylated cofilin (Figure 1A). A protein of 49 kDa bound
cofilin regardless of its phosphorylation state. In order
to exclude the possibility that the p31/XAC-P interaction
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resulted from cofilin phosphorylation on other sites in10550 North Torrey Pines Road
addition to Ser3 (catalyzed by unidentified kinases dur-La Jolla, California 92037
ing the in vitro phosphorylation reaction), overlay assays
were performed with the LIMK phosphorylation site mu-
tant XAC-S3A, which was subjected to a typical in vitro
kinase reaction. As shown in the bottom panel of FigureSummary
1A, p31 did not detectably associate with XAC-S3A.
These results suggest that p31 represents a protein thatThe functionality of the actin cytoskeleton depends
specifically binds to Ser3-phosphorylated Xenopuson a dynamic equilibrium between filamentous and
cofilin.monomeric actin. Proteins of the ADF/cofilin family are
essential for the high rates of actin filament turnover
observed in motile cells through regulation of actin Identification of p31 as 14-3-3
polymerization/depolymerization cycles [1, 2]. Rho by Mass Spectrometry
GTPases act through p21-activated kinase-1 (Pak-1) Employing the XAC-P overlay assay to detect p31, the
[3] and Rho kinase [4] to inhibit cofilin activity via the protein was purified to near homogeneity (Figures 1B–
LIM kinase (LIMK)-mediated phosphorylation of cofilin 1D) and was sequenced by MS/MS tandem mass spec-
on Ser3 [5, 6]. We report the identification of 14-3-3 trometry. The peptide sequences obtained corre-
as a novel phosphocofilin binding protein involved in sponded exclusively to members of the 14-3-3 family of
the maintenance of the cellular phosphocofilin pool. proteins. Notably, 14-3-3was by far the most abundant
A Ser3 phosphocofilin binding protein was purified 14-3-3 protein present in the fraction, and the generated
from bovine brain and was identified as 14-3-3 by peptides encompassed about 70% of the sequence of
mass spectrometry. The phosphorylation-dependent 14-3-3. The 14-3-3 proteins are a family of ubiquitously
interaction between cofilin and 14-3-3 was confirmed expressed and evolutionarily conserved molecules, in-
in pulldown and coimmunoprecipitation experiments. cluding seven highly homologous mammalian isoforms
Both Ser3 phosphorylation and a 14-3-3 recognition (, , , , , , and ) that primarily exist as homo- or
motif in cofilin are necessary for 14-3-3 binding. The heterodimers. 14-3-3 proteins play key regulatory roles
expression of 14-3-3 increases phosphocofilin levels, in signal transduction, cell cycle control, and cell survival
and the coexpression of 14-3-3 with LIMK further by binding to a multitude of functionally diverse ligands
and affecting their enzymatic activities, directing theirelevates phosphocofilin levels and potentiates LIMK-
subcellular localization, or altering their association withdependent effects on the actin cytoskeleton. This po-
other cellular components [7–10]. To our knowledge, atentiation of cofilin action appears to be a result of
role for 14-3-3 proteins in cytoskeletal regulation hasthe protection of phosphocofilin from phosphatase-
not been reported.mediated dephosphorylation at Ser3 by bound 14-3-
3 . Taken together, these results suggest that 14-3-
3 proteins may play a dynamic role in the regulation 14-3-3 and Ser3 Phosphocofilin Associate
of cellular actin structures through the maintenance In Vitro and In Vivo
of phosphocofilin levels. The interaction between 14-3-3 and cofilin was con-
firmed in pulldown binding experiments with GST-14-
3-3. Cos-1 cells were either mock transfected or trans-
Results and Discussion fected with the constitutively active LIMK1 fragment Kd3
[3, 5, 6] in order to specifically increase the endogenous
Purification of a Ser3 Phosphocofilin pool of Ser3 phosphocofilin. In lysates of control cells,
Binding Protein only a small amount of cofilin was able to bind GST-
Bovine brain cytosol was fractionated by DEAE anion 14-3-3. In contrast, the cofilin/14-3-3 interaction was
exchange chromatography, and column fractions were strongly increased by expression of Kd3 (Figure 1E).
tested for cofilin binding proteins by using an overlay Similar results were obtained with GST-14-3-3 (not
assay with in vitro Ser3-phosphorylated Xenopus cofilin shown). Immunoblotting of precipitated proteins with
(XAC-P). Xenopus and human cofilin are highly homolo- -phosphocofilin antibodies clearly confirmed that 14-
gous, and their actin binding and -depolymerizing activi- 3-3 specifically pulled down the phosphorylated cofilin
ties are equally inhibited by LIMK-mediated Ser3 phos- in both control and Kd3-expressing cells. Furthermore,
phorylation [1]. We observed that a 31 kDa protein (p31) pretreatment of cell lysates with the serine/threonine
bound to Ser3-phosphorylated cofilin but not to unphos- phosphatases PP1 and PP2A (which dephosphorylate
cofilin in vitro; [11] and data not shown) completely abol-
ished the cofilin/14-3-3 interaction.
Figure 1F shows that endogenous cofilin coimmuno-1Correspondence: bokoch@scripps.edu
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Figure 1. Purification and Identification of a Ser3 Phosphocofilin Binding Protein
(A–C) Bovine brain cytosol was fractionated as described in the Experimental Procedures by (A) DEAE, (B) SEC, and (C) Mono-Q column
chromatography and was tested for cofilin binding proteins by using an overlay assay with purified XAC, XAC-P, or XAC-S3A. Far Western
immunoblots detecting bound cofilin are shown. p31 is indicated by an arrow, and the position of molecular weight marker proteins is given
on the left.
(D) A silver-stained gel of the Mono-Q fraction #24 after SDS-PAGE separation is shown. p31 is indicated by an arrowhead and was identified
as 14-3-3 by tandem mass spectrometry.
(E) Cos-1 cells were transfected with empty vector or the LIMK1 fragment Kd3 to increase the endogenous pool of Ser3 phosphocofilin and
were incubated with GST or GST-14-3-3 immobilized on beads. In some cases, cell lysates were treated with 0.1 U of PP1 and PP2A before
incubation with glutathione beads. Left panel: GST-14-3-3 beads specifically associate with cofilin. The interaction is enhanced by expression
of Kd3. Right panel: 14-3-3 preferentially binds to phosphocofilin, as pretreatment with PP1/PP2A abolishes the interaction.
(F) Left panel: HA-14-3-3 and - were expressed in Cos-1 cells, immunoprecipitated with anti-HA antibodies, and probed for coimmunoprecipi-
tated cofilin. Both 14-3-3 isoforms associate with cofilin. The right panel shows the corresponding expression and immunoprecipitation of
endogenous and transfected 14-3-3 proteins, as detected with the pan-14-3-3 antibody 14-3-3. The control lanes represent immunoprecipita-
tion experiments performed in the absence of anti-HA antibodies. All results shown are representative of at least two independent experiments.
precipitated with HA-14-3-3, which is indicative of sta- that the interaction is not restricted to a single 14-3-3
isoform. Interestingly, 14-3-3 was able to immunopre-ble complex formation in cells. Cofilin also associated
with HA-14-3-3, albeit to a lesser extent, suggesting cipitate cofilin even in the absence of increased LIMK
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Figure 2. Mapping of the 14-3-3 Binding
Site on Human Cofilin
(A) The indicated mutants of human cofilin
or the empty vector control were transfected
into Cos-1 cells, and cell lysates were incu-
bated with purified GST-14-3-3 immobilized
on glutathione beads. Precipitated proteins
were probed with anti-cofilin antibody or anti-
phosphocofilin antibody. The bottom panel
demonstrates comparable expression of the
cofilin mutants in cell lysates. The mutation
of both the regulatory phosphorylation site
and the predicted 14-3-3 binding motif (cofi-
linS3,23,24A) abolished the cofilin/14-3-3 associ-
ation.
(B) Pulldown experiments were performed
with wild-type cofilin in the presence or ab-
sence of 0.1 	mol of a peptide comprising
the eight amino-terminal residues of human
cofilin. The cofilin/14-3-3 association is sig-
nificantly enhanced in the presence of pep-
tide. All results shown are representative of
at least two independent experiments.
signaling. Results discussed below show that the ex- cells and tested their binding to GST-14-3-3. The em-
ployed mutants lack the regulatory phosphorylation sitepression of 14-3-3 itself can lead to an elevation of the
basal phosphocofilin pool, which typically constitutes (cofilinS3A) and/or contain a modification in the predicted
14-3-3 recognition motif (cofilinS3,23,24A or cofilinS23,24A). Asup to 20%–50% of the total cofilin in nontransformed
cells [12]. shown in Figure 2A, mutation of Ser3 to Ala clearly re-
duced 14-3-3 binding, confirming that Ser3 phosphory-The affinity of purified Ser3 phosphocofilin for 14-3-
3 was determined by a solid-phase binding assay (see lation of cofilin is important for the association with
14-3-3. CofilinS23,24A, which is Ser3 phosphorylated asFigure S1). Binding was best fit to a one binding site
model, with a Kd of 0.6–1 
 107 M, suggesting equiva- efficiently as wild-type cofilin, also bound 14-3-3 com-
parable to wild-type cofilin. In contrast, the mutation oflent and independent function of the two ligand binding
sites on the 14-3-3 dimer. In summary, the in vitro and both the regulatory phosphorylation site and the pre-
dicted 14-3-3 binding motif (cofilinS3,23,24A) abolished thein vivo association of phosphocofilin and 14-3-3 is con-
sistent with the phosphorylation-dependent interaction cofilin/14-3-3 association. Similar results were obtained
when GST-14-3-3 was used (not shown). Thus, bothobserved in overlay assays.
the Ser3-phosphorylated amino terminus and the 14-3-
3 consensus site of cofilin are functionally involved inMapping of the 14-3-3 Binding Site
on Human Cofilin 14-3-3 binding.
It is tempting to speculate that, when cofilin is active,Numerous 14-3-3 binding proteins associate with 14-
3-3 through a phosphorylated serine contained within the unphosphorylated amino terminus of cofilin folds
over the putative 14-3-3 recognition motif, thus imped-a prototypical 14-3-3-recognition motif, RSxpSxP
(where x represents any amino acid and pS stands for ing 14-3-3 binding. Phosphorylation of Ser3 would then
lead to a conformational change of the molecule, render-phosphorylated serine) [7]. Human cofilin contains one
putative 14-3-3 recognition sequence (RKS23S24TP). Al- ing the 14-3-3 recognition motif more accessible to 14-
3-3. In support of this hypothesis, we observed that athough Ser24 in this motif exists within a conserved
CaM kinase II consensus sequence, it is not a phospho- peptide comprising the eight amino-terminal amino
acids of human cofilin, which might compete with thisacceptor site in vivo [13]. It seems reasonable to assume
that the extreme amino terminus of cofilin also plays a putative intramolecular association, significantly en-
hanced cofilin binding to 14-3-3 (Figure 2B).role in 14-3-3 binding, since Ser3 phosphocofilin specifi-
cally associates with 14-3-3 (Figure 1). However, the
amino acid sequences surrounding Ser3 do not contain The Expression of 14-3-3 Increases
Phosphocofilin Levelsany of the described 14-3-3 interaction motifs. We note
that some 14-3-3 binding partners interact with 14-3-3 To investigate the functional relevance of the cofilin/14-
3-3-interaction, 14-3-3 was transiently transfected intoin a phosphorylation-specific manner, but do not contain
prototypical 14-3-3 recognition motifs [8]. Cos-1 or BHK-21 cells, and effects on steady-state
phosphocofilin levels were studied biochemically andIn order to map the 14-3-3 binding site(s) on cofilin,
we expressed point mutants of human cofilin in Cos-1 by immunofluorescence analysis. Remarkably, 14-3-3
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Figure 3. The Expression of 14-3-3 In-
creases Phosphocofilin Levels
(A) Cos-1 cells or BHK-21 cells were trans-
fected with HA-14-3-3 and/or the LIMK1
fragment Kd3; then, the lysates were probed
with the indicated antibodies. Blots were
stripped and reprobed for cofilin with-cofilin
antibody to compare total cofilin in cell ly-
sates.
(B) Immunofluorescence analysis of phos-
phocofilin levels and distribution in BHK-21
cells. Cells expressing the indicated trans-
genes are marked by arrows. The expression
of 14-3-3 leads to a significant increase in
the cytosolic phosphocofilin immunosignal,
which is enhanced by coexpression with wt-
LIMK. Representative cells from three inde-
pendent transfections are shown. The scale
bar represents 10 	m.
(C) Top panel: in vitro association of LIMK
with immobilized GST-14-3-3. The binding
was markedly reduced after treatment of cell
lysates with PP1/PP2A. Equal expression of
LIMK was verified by probing cell lysates with
anti-LIMK antibodies.
(D) 14-3-3 binding to LIMK does not affect
the LIMK-dependent cofilin phosphorylation.
A representative autoradiogram of Xenopus
cofilin phosphorylated with LIMK in the pres-
ence or absence of 14-3-3 purified from bo-
vine brain is shown. Similar results were ob-
tained with purified GST-14-3-3. The bottom
panel shows a corresponding Coomassie
blue-stained gel. The results shown are rep-
resentative of at least two independent ex-
periments.
elevated the phosphocofilin pool to a similar extent as 3B) could be performed after shorter expression times,
and staining for endogenous cofilin under these condi-the constitutively active LIMK1 fragment Kd3 in Cos-1
cells (Figure 3A). The coexpression of 14-3-3 and Kd3 tions did not show any detectable decrease in protein
levels (data not shown). The expression of 14-3-3 ledfurther increased the amount of phosphocofilin com-
pared to the effect of each protein alone. Densitometric to a diffuse increase in cytoplasmic phosphocofilin
staining, consistent with the largely cytoplasmic distri-analysis of the phosphocofilin/cofilin ratios showed that
14-3-3 or Kd3 alone increased relative phosphocofilin bution of 14-3-3 proteins [14]. Wild-type LIMK1 pro-
moted an accumulation of phosphocofilin predomi-levels 10- to 13-fold compared to the vector control,
whereas coexpression of both led to a 57-fold increase nantly in membrane ruffles, where it colocalized with
actin and 14-3-3 (see [5, 6], and data not shown). Thein phosphocofilin. In BHK-21 cells, we frequently ob-
served a downregulation of total cofilin protein coinci- coexpression of both 14-3-3 and LIMK1 led to a further
increase in largely cytoplasmic phosphocofilin staining.dent with 14-3-3 and/or Kd3 expression. However, densi-
tometric comparison of the phosphocofilin immunosignals In addition, these cells showed a strikingly altered mor-
phology reminiscent of the phenotypical changes en-with the amounts of endogenous cofilin revealed a 14-
3-3- and/or Kd3-dependent increase in the phospho- countered in cells expressing high amounts of the con-
stitutively active LIMK1 fragment Kd3 [3, 15].cofilin pool similar to the levels obtained in Cos-1 cells
(14-3-3: 3-fold, Kd3: 10-fold, 14-3-3  Kd3: 58-fold). Testicular protein kinase 1 (TESK1), an integrin-acti-
vated serine/threonine kinase with homology to LIMK1,Immunofluorescence analysis in BHK-21 cells (Figure
Current Biology
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Figure 4. 14-3-3 Potentiates the LIMK-
Induced Actin Phenotype
(A) BHK-21 cells were transfected with HA-
14-3-3 and/or wild-type LIMK (arrows), and
the actin cytoskeleton was visualized. The
scale bar represents 10 	m.
(B) Distribution of actin cytoskeletal pheno-
types in the population of cells expressing
the indicated proteins. A minimum of 100
cells was scored in a blinded manner. Each
transfection was repeated twice with similar
results.
also induces actin cytoskeletal reorganization through cate 14-3-3 proteins in the control of the actin cytoskele-
ton. However, we cannot formally exclude the possibilityphosphorylation of cofilin on Ser3 [16, 17]. Interestingly,
TESK1 was recently shown to bind 14-3-3, resulting in that binding of 14-3-3 to LIMK regulates the phosphory-
lation of an unidentified LIMK substrate that also con-an inhibition of TESK1 kinase activity [18]. In in vitro
kinase assays with immunoprecipitated, myc-tagged trols cofilin activity.
TESK1 and TESK2, we were, however, unable to detect
any effect of up to 6 	g purified GST-14-3-3 or - on 14-3-3 Potentiates the LIMK-Induced
Actin PhenotypeTESK-dependent cofilin phosphorylation (data not
shown). Additionally, the expression of endogenous Expression analysis of wild-type and mutant LIMK in
different cell types has revealed dose- and activity-TESK1 or TESK2 proteins in Cos-1 or BHK-21 cells ap-
peared to be very low, since neither isoform was de- dependent effects of LIMK on the actin cytoskeleton
[5, 6, 15]. To obtain functional evidence that 14-3-3 istected in lysates of up to 5 
 106 cells when the original
antibodies described in [16–18] were used (data not involved in cofilin-controlled actin dynamics, we ex-
pressed 14-3-3 and/or wild-type LIMK in BHK-21 cells.shown). We further investigated whether LIMK1 might
be an interaction partner of 14-3-3. As shown in Figure As shown in Figure 4A, 14-3-3 induced the formation
of membrane protrusions and triggered actin aggrega-3C, LIMK1 indeed associated with GST-14-3-3 in pull-
down experiments. However, 14-3-3 (and 14-3-3; data tion in a subset of cells. The character of these actin-
rich protrusions is at present unclear. Consistent withnot shown) had no effect on the LIMK1-mediated cofilin-
phosphorylation in in vitro kinase assays (Figure 3D). published observations, cells overexpressing wild-type
LIMK were generally characterized by exaggeratedThese results support the idea that the 14-3-3-
dependent increase in cellular phosphocofilin is a direct membrane protrusions, and only a small subset of LIMK
expressors contained actin aggregates. However, cellsresult of the phosphocofilin/14-3-3 interaction and impli-
Brief Communication
1709
against phosphatase attack and are in good agreement
with published observations. For example, it has been
reported that 14-3-3 blocked Raf [19, 20] and BAD [21]
from PP1/PP2A-mediated dephosphorylation.
Conclusions
In summary, our results identify a previously uncharac-
terized role for 14-3-3 proteins in modulating the actin
depolymerizing and/or severing functions of cofilin. Our
data strongly indicate that LIMK and 14-3-3 act cooper-
atively to control actin cytoskeletal dynamics by increas-
ing and stabilizing the levels of phosphocofilin. It will be
of interest to evaluate whether the scaffolding function
of 14-3-3 proteins plays any additional role in organizing
and regulating the interplay between LIMK, cofilin, and
various phosphocofilin regulatory phosphatases.
Supplementary Material
Supplementary material including Experimental Procedures, Table
S1, and Figure S1 can be found at http://images.cellpress.com/
supmat/supmatin.htm.
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